欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1665/001
药品名称
Naloxone Adapt
活性成分
NALOXONE HYDROCHLORIDE dihydrate 2.0 mg
剂型
Nasal spray, solution
上市许可持有人
Emergent Operations Ireland Limited
参考成员国 - 产品名称
Sweden (SE)
Narcan
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
France (FR)
Italy (IT)
许可日期
2017/12/14
最近更新日期
2024/01/02
药物ATC编码
V03AB15 naloxone
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1665_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1665_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1665_001_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1665_001_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase